Company Profiles

driven by the PitchBook Platform

Advantagene

Advantagene
1999 FOUNDED
PRIVATE STATUS
11-50 EMPLOYEES
Series A LATEST DEAL TYPE
$16.4M LATEST DEAL AMOUNT
$16.4M TOTAL AMOUNT RAISED
Description

Operator of a biopharmaceutical company focused on oncology and immunotherapy. The company focuses on preventing the recurrence and progression of cancer through the use of therapeutics in oncology and immunotherapy.

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Pharmaceuticals
Drug Discovery
Primary Office
440 Lexington Street
Newton, MA 02466
United States

+1 (617) 916-5445
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Advantagene’s full profile, request a free trial.

Advantagene Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Later Stage VC (Series A) 06-Sep-2016 $16.4M $16.4M 00000 Completed Clinical Trials - Phase 3
2. Grant 01-Jan-2014 000.00 Completed Generating Revenue
1. Grant 25-Mar-2011 $500k Completed Generating Revenue
To view this company’s complete deal history including valuation and funding request access »

Advantagene Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned
Series A 00,000,000 00.000000 00.0 00.0 00 00.0 00.000
To view this company’s complete Cap Table request access »

Advantagene Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Massachusetts Life Sciences Center Government 000 0000 000000 0
U.S. Department of Health and Human Services Government 000 0000 000000 0

You’re viewing 2 of 2 investors.

Advantagene Executive Team (3)

Name Title Board
Seat
Contact
Info
Estuardo Aguilar-Cordova Ph.D Chief Executive Officer, Chairman and Co-Founder
Stephen Rocamboli JD Chief Business Officer
Laura Aguilar Ph.D Chief Medical Officer

You’re viewing 3 of 3 executives.

Advantagene Board Members (6)

Name Representing Role Since Contact
Info
Alan Smith Advantagene Board Member 000 0000
Estuardo Aguilar-Cordova Ph.D Advantagene Chief Executive Officer, Chairman and Co-Founder 000 0000
Fred Mermelstein Ph.D Self Board Member 000 0000
Glenn Mattes Self Board Member 000 0000
Mitchell Finer Ph.D Self Board Member 000 0000
You’re viewing 5 of 6 board members. Get the full list »